Effectiveness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end-stage liver disease.
Effectiveness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end-stage liver disease.
复制标题
原位肝移植对终末期肝病患者胆固醇代谢恢复的有效性。
DOI:
10.1016/0016-5085(87)90241-1
复制
发表时间:
1987
期刊:
影响因子:
29.4
通讯作者:
Bistrian,BR
中科院分区:
文献类型:
--
作者:
Palombo,JD;Lopes,SM;Zeisel,SH;Jenkins,RL;Albers,JJ;Blackburn,GL;Bistrian,BR
The effects of end-stage liver disease and orthotopic liver transplantation on components that modulate cholesterol esterification in plasma were assessed. In comparison with healthy controls, patients with end-stage liver disease had significantly decreased concentrations of lecithin-cholesterol acyltransferase mass, apolipoprotein A-1, total phospholipids, and both total and esterified cholesterol. Elevated phosphatidylcholine and reduced lysophosphatidylcholine fractions indicated impairment of cholesterol esterification by lecithin-cholesterol acyltransferase. Constituent fatty acids of the patients' phospholipids and cholesterol esters manifested increased saturation and a concomitant reduction of polyunsaturated fatty acids, indicative of impaired hepatic elongation and desaturation of essential fatty acids. By the third month after hepatic replacement, the plasma concentrations of total cholesterol, phospholipids, lecithin-cholesterol acyltransferase, and apolipoprotein A-1 were comparable to those of the healthy subjects. Despite the improvement in cholesterol esterification and the rapid normalization of the enzyme and cofactor involved in this process, the percentage of phosphatidylcholine remained significantly higher and the percentages of lysophosphatidylcholine and esterified cholesterol remained significantly lower than in the healthy subjects at 6 mo. Phospholipid and cholesterol ester fatty acid patterns attained normalcy by the sixth month after transplant. We conclude that hepatic transplantation effectively restores cholesterol and essential fatty acid metabolism in patients with end-stage liver disease.
登录
查看更多内容
影响因子:
29.4
作者:
P. Monroe;Z. Vlahcevic;L. Swell
通讯作者:
L. Swell
DOI:
10.3109/00365516609051816
发表时间:
1966
影响因子:
2.1
作者:
E. Gjone;O. Orning
通讯作者:
O. Orning
DOI:
10.1056/nejm197010152831604
发表时间:
1970
期刊:
The New England journal of medicine
影响因子:
--
作者:
J. B. Simon;R. Scheig
通讯作者:
R. Scheig
DOI:
10.1080/00365517809104894
发表时间:
1978
期刊:
Scandinavian journal of clinical and laboratory investigation. Supplementum
影响因子:
--
作者:
G. Assmann;G. Schmitz;N. Donáth;D. Lekim
通讯作者:
D. Lekim
DOI:
--
发表时间:
1981
期刊:
Biochemical and Biophysical Research Communications - BBRC
影响因子:
--
作者:
R. Verdery
通讯作者:
R. Verdery